Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 3915
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49407
I can't count how many tomes hindsight has kicked
(2)
BooDog
10/02/2018 8:24:04 AM
49406
I was being a little sarcastic... I'd be estatic
(2)
bejamin
10/02/2018 8:20:43 AM
49405
I can't afford to double down how much money I
(1)
BooDog
10/02/2018 8:17:51 AM
49404
I wish I could own 7billion shares like half the
(2)
bejamin
10/02/2018 8:03:49 AM
49403
I lowered to .151 before open yesterday. thought
(2)
BooDog
10/02/2018 5:48:26 AM
49402
26% marked today! Go IPIX!!!
(1)
AlanC
10/01/2018 5:37:09 PM
49401
Youre shoveling alright..but it aint
(5)
B.Izzy
10/01/2018 3:17:46 PM
49400
I saw where Novartis got BTD for Kisqali
(2)
smokenhot
10/01/2018 2:18:14 PM
49399
Dont sell, you wont lose a dime,
(1)
scgmck1
10/01/2018 1:54:34 PM
49398
Gosh guys, Squott thinks were out of dough and
(4)
scgmck1
10/01/2018 1:51:56 PM
49397
Sure hope you're right. Losing money faster than
Squar
10/01/2018 1:51:28 PM
49396
BTD alone takes IPIX over .50. Aspire deal still
(3)
smokenhot
10/01/2018 1:22:07 PM
49395
Is that so? What's going to turn this around
(2)
Squar
10/01/2018 12:46:52 PM
49394
More pure unadulterated bullshit from the cheap
(7)
scgmck1
10/01/2018 12:38:22 PM
49393
Thanks Sox. I always appreciate your insight.
Loose Lips
10/01/2018 12:27:30 PM
49392
No one but the stock price. You must have,gotten
(2)
Squar
10/01/2018 12:26:21 PM
49391
Really knocking it out of the
(2)
bejamin
10/01/2018 12:20:48 PM
49390
Check. Almost checkmate. No one's
(4)
BooDog
10/01/2018 10:30:46 AM
49389
I agree that IPIX longs will soon have lots to
AlanC
10/01/2018 8:45:32 AM
49388
retail can't .. but NR can slide via those t
(4)
4kids
10/01/2018 7:59:09 AM
49387
"You cannot trade OTC Bulletin Board securities
BooDog
10/01/2018 6:59:07 AM
49386
And the batteries are still bad. He's working on
incubus
09/30/2018 3:13:00 PM
49385
exactly but why it's worth noting the *math* in
(2)
4kids
09/30/2018 12:56:39 PM
49384
or to put it another way .. 2017 YTD Volume on
(4)
4kids
09/30/2018 12:53:55 PM
49383
And that is why there are now purportedly bullish
Drano
09/30/2018 12:51:10 PM
49382
folks always have to do what is best for
(8)
4kids
09/30/2018 11:58:13 AM
49381
I think what most troubles investors, outside of
(2)
Commando911
09/30/2018 11:42:49 AM
49380
Lovaza was the competitor by Glaxo. Its been a
(1)
NickAidenNY
09/30/2018 10:34:09 AM
49379
I am the one who brought up AMRN since I bought
(3)
NickAidenNY
09/30/2018 10:29:27 AM
49378
I know based on a PM I received some longs are
(2)
AlanC
09/30/2018 8:58:44 AM
49377
Posted this at the swamp which IMO has few posts
(3)
AlanC
09/30/2018 8:57:03 AM
49376
Great posts Mo but your #'s are quite "tame".
(4)
Kelt
09/29/2018 8:36:48 PM
49375
NOT GOING TO HAPPEN!!! Kelt
(2)
Kelt
09/29/2018 8:23:37 PM
49374
Everyone on a message board has an opinion. The
(5)
Mo
09/29/2018 7:21:57 PM
49373
Step 1: The milestone agreement in June was to
(7)
Mo
09/29/2018 7:21:24 PM
49372
Step 2 : Flush with cash from the Brilacidin deal
(6)
Mo
09/29/2018 7:20:46 PM
49371
Step 3: With Brilacidin and Prurisol now under
(7)
Mo
09/29/2018 7:19:55 PM
49370
Step 4 : Brilacidin and Prurisol have advanced
(8)
Mo
09/29/2018 7:19:12 PM
49369
Elon Musk's blabbermouth lies cost him 20 million
(2)
Drano
09/29/2018 6:06:07 PM
49367
SOX making sure the OM and UP patents are valid
(2)
smokenhot
09/29/2018 5:12:58 PM
49366
The only reason I feel they are more likely to
(2)
NickAidenNY
09/29/2018 4:52:09 PM
49365
A:Celgene is not a good example and B:I don't see
Kelt
09/29/2018 4:33:10 PM
49363
I feel the 10k broke out Keventrin specifically
(3)
NickAidenNY
09/29/2018 4:08:30 PM
49362
I will not agree or disagree with your theory as
(5)
Kelt
09/29/2018 3:42:58 PM
49361
Dr. Menon is in his mid-70's. He has done the
(2)
Drano
09/29/2018 3:42:17 PM
49360
I think Dr. Menons termination was to reduce
(2)
sox0407
09/29/2018 3:12:52 PM
49359
I really feel from all my readings into the 10k
(8)
NickAidenNY
09/29/2018 2:22:26 PM
49358
You said a mouthful there, brother. So
scgmck1
09/29/2018 1:15:36 PM
49357
Yes it will make the upside more dramatic when
(1)
Trading Pro Broker
09/29/2018 10:53:49 AM
49356
Saw that. They wont be the first. I expect
Commando911
09/29/2018 10:50:50 AM
Newer
Older
Recent Articles
Navigator Group Purchasing Partners with Foodbuy for Enhanced Services
NCAA President Charlie Baker to Discuss College Sports Evolution
NVIDIA's Sales Surge: The Greenlight for Growth Ahead
James Wynn's Risky Return to High-Leverage Bitcoin Trading
ProLogic ITS Partners with Signal 8 to Enhance Public Safety
Unity Software Experiences Stock Surge Following Analyst Upgrade
Kezar Life Sciences Advances in Autoimmune Hepatitis Trials
OSE Immunotherapeutics Reveals Recent Liquidity Contract Update
IPSEN's Recent Buy-Back Activities: Insights and Analysis
Exosens Expands Night Vision Capabilities Through NVLS Deal
Investment Growth: What $1000 in RB Global Could Yield
Zensai's Major Recognition as a Leading AI Innovator
Investigation Launched: Potential Class Action Against WAMCO
Guideline Faces Recommendations on 401(k) Claims from NAD
Chartwells Higher Education Achieves 25 NACUFS Awards in 2025
AGCO Takes Swift Action to Suspend Licenses of Fergus Bar
GIGABYTE Unveils New AI PC Models for Enthusiasts and Gamers
Analyzing the P/E Ratio for First United Inc. Stock Investors
The Drive Towards Fusion Energy: America's New Manhattan Project
Primak Construction Group: A Bold New Era for Growth
Whales Bet Big on Procter & Gamble: What You Should Know
Revolutionizing Edge AI: SiMa.ai Partners with Cisco
Analyzing Oscar Health's Stock Movements and Trends
Tetrate Introduces Agent Router for Enhanced GenAI Flexibility
Exploring the Recent Trends in American Airlines Options Trading
Investors Can Join Class Action Against Hims & Hers Health
United Airlines Earnings: Will Q2 Performance Elevate Stocks?
Behr Paint and Google Cloud Transform Color Choices with AI
Exciting Highlights of the 2025 ESL Rochester Fringe Festival
Empowering Food Security: Fidelis Care's Grant Opportunities
Federal Signal's Upcoming Earnings Call Brings Excitement
Investigation of Stock Transactions: TASK, VBTX, TURN Insights
Investigating Shareholder Rights: OLO and GNTY Sales Reviewed
BMO Launches Recovery Fund to Support Wildfire Impacted Communities
JMOON Launches Innovative Facial Toning Device in the USA
Explore Innovative Opportunities at EmTech MIT 2025
Charming Cottages Designed by Michael Kramer and Lilly Pulitzer
JPMorgan Chase's Strong Q2 Results Signal Future Growth
Exploring the Future of Crypto Mining with EarnMining App
Exploring the New Frontiers of Live Streaming with Pump.fun
Echelon Mark Unveils Innovative Web3 and DeFi Training Program
IPSEN's Strategic Share Buyback Program Insights for Investors
Cramer's Bold Proposal: Shift Apple from Buybacks to AI Innovation
Exosens Expands Night Vision Technology with Strategic NVLS Deal
Investors Under Scrutiny: Legal Probe on Biohaven's Practices
OSE Immunotherapeutics' Mid-Year Update on Liquidity Initiatives
PepGen Inc. Faces Legal Investigation Over Investor Claims
Antimony Resources Drum Up Interest with Recent Drill Program
AgEagle Aerial Systems Revolutionizes Sugarcane Farming in Brazil
Investors Alert: Organon Faces Legal Investigation Over Losses